These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21099321)

  • 1. Decreased senescence marker protein-30 could be a factor that contributes to the worsening of glucose tolerance in normal aging.
    Hasegawa G
    Islets; 2010; 2(4):258-60. PubMed ID: 21099321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senescence marker protein-30/gluconolactonase deletion worsens glucose tolerance through impairment of acute insulin secretion.
    Hasegawa G; Yamasaki M; Kadono M; Tanaka M; Asano M; Senmaru T; Kondo Y; Fukui M; Obayashi H; Maruyama N; Nakamura N; Ishigami A
    Endocrinology; 2010 Feb; 151(2):529-36. PubMed ID: 19934374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of senescence marker protein 30 exacerbates angiotensin II-induced cardiac remodelling.
    Misaka T; Suzuki S; Miyata M; Kobayashi A; Shishido T; Ishigami A; Saitoh S; Hirose M; Kubota I; Takeishi Y
    Cardiovasc Res; 2013 Aug; 99(3):461-70. PubMed ID: 23723062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related oxidant stress with senescence marker protein-30 deficiency plays a pivotal role in coronary artery spasm.
    Hoshino Y; Yamada S; Saitoh S; Machii H; Mizukami H; Miyata M; Misaka T; Ishigami A; Takeishi Y
    Coron Artery Dis; 2013 Mar; 24(2):110-8. PubMed ID: 23291859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced blood glucose levels, increased insulin levels and improved glucose tolerance in alpha2A-adrenoceptor knockout mice.
    Savontaus E; Fagerholm V; Rahkonen O; Scheinin M
    Eur J Pharmacol; 2008 Jan; 578(2-3):359-64. PubMed ID: 17964569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taurine supplementation prevents morpho-physiological alterations in high-fat diet mice pancreatic β-cells.
    Ribeiro RA; Santos-Silva JC; Vettorazzi JF; Cotrim BB; Mobiolli DD; Boschero AC; Carneiro EM
    Amino Acids; 2012 Oct; 43(4):1791-801. PubMed ID: 22418865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascorbic acid prevents protein oxidation in livers of senescence marker protein-30/gluconolactonase knockout mice.
    Sato Y; Amano A; Kishimoto Y; Takahashi K; Handa S; Maruyama N; Ishigami A
    Geriatr Gerontol Int; 2014 Oct; 14(4):989-95. PubMed ID: 24118935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senescence marker protein-30 deficiency impairs angiogenesis under ischemia.
    Yamauchi H; Miura S; Owada T; Saitoh S; Machii H; Yamada S; Ishigami A; Takeishi Y
    Free Radic Biol Med; 2016 May; 94():66-73. PubMed ID: 26912033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senescence marker protein-30 knockout mouse as an aging model.
    Maruyama N; Ishigami A; Kuramoto M; Handa S; Kubo S; Imasawa T; Seyama K; Shimosawa T; Kasahara Y
    Ann N Y Acad Sci; 2004 Jun; 1019():383-7. PubMed ID: 15247050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the TLR signaling molecule TRIF in β-cell function and glucose homeostasis.
    Hutton MJ; Soukhatcheva G; Johnson JD; Verchere CB
    Islets; 2010; 2(2):104-11. PubMed ID: 21099302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance.
    Terauchi Y; Takamoto I; Kubota N; Matsui J; Suzuki R; Komeda K; Hara A; Toyoda Y; Miwa I; Aizawa S; Tsutsumi S; Tsubamoto Y; Hashimoto S; Eto K; Nakamura A; Noda M; Tobe K; Aburatani H; Nagai R; Kadowaki T
    J Clin Invest; 2007 Jan; 117(1):246-57. PubMed ID: 17200721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological significance of senescence marker protein-30.
    Maruyama N; Ishigami A; Kondo Y
    Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S88-98. PubMed ID: 20590846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction.
    Misaka T; Suzuki S; Miyata M; Kobayashi A; Ishigami A; Shishido T; Saitoh S; Kubota I; Takeishi Y
    Biochem Biophys Res Commun; 2013 Sep; 439(1):142-7. PubMed ID: 23933320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic ABCA1 expression improves β-cell function and glucose tolerance.
    de Haan W; Karasinska JM; Ruddle P; Hayden MR
    Diabetes; 2014 Dec; 63(12):4076-82. PubMed ID: 25028523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal and dietary fat content-dependent islet adaptation to high-fat feeding-induced glucose intolerance in mice.
    Winzell MS; Magnusson C; Ahrén B
    Metabolism; 2007 Jan; 56(1):122-8. PubMed ID: 17161234
    [TBL] [